Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ELVN

Enliven Therapeutics (ELVN)

Enliven Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ELVN
FechaHoraFuenteTítuloSímboloCompañía
18/06/202416:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELVNEnliven Therapeutics Inc
10/06/202417:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
29/05/202415:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ELVNEnliven Therapeutics Inc
29/05/202415:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ELVNEnliven Therapeutics Inc
29/05/202415:05GlobeNewswire Inc.Enliven Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:ELVNEnliven Therapeutics Inc
14/05/202415:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELVNEnliven Therapeutics Inc
14/05/202415:05GlobeNewswire Inc.Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business UpdateNASDAQ:ELVNEnliven Therapeutics Inc
11/04/202406:55GlobeNewswire Inc.Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid LeukemiaNASDAQ:ELVNEnliven Therapeutics Inc
09/04/202415:05GlobeNewswire Inc.Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of DirectorsNASDAQ:ELVNEnliven Therapeutics Inc
28/03/202415:05GlobeNewswire Inc.Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024NASDAQ:ELVNEnliven Therapeutics Inc
19/03/202407:30GlobeNewswire Inc.Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline UpdatesNASDAQ:ELVNEnliven Therapeutics Inc
14/03/202415:05GlobeNewswire Inc.Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business UpdateNASDAQ:ELVNEnliven Therapeutics Inc
27/02/202415:05GlobeNewswire Inc.Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:ELVNEnliven Therapeutics Inc
20/02/202418:35Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ELVNEnliven Therapeutics Inc
16/02/202415:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELVNEnliven Therapeutics Inc
14/02/202419:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ELVNEnliven Therapeutics Inc
09/11/202315:05GlobeNewswire Inc.Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ELVNEnliven Therapeutics Inc
10/08/202315:05GlobeNewswire Inc.Enliven Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:ELVNEnliven Therapeutics Inc
06/07/202315:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELVNEnliven Therapeutics Inc
04/07/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELVNEnliven Therapeutics Inc
26/06/202305:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELVNEnliven Therapeutics Inc
19/05/202315:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELVNEnliven Therapeutics Inc
11/05/202315:05GlobeNewswire Inc.Enliven Therapeutics Highlights Business Achievements and Reports First Quarter 2023 Financial ResultsNASDAQ:ELVNEnliven Therapeutics Inc
10/05/202308:46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ELVNEnliven Therapeutics Inc
21/03/202315:08Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ELVNEnliven Therapeutics Inc
06/03/202316:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ELVNEnliven Therapeutics Inc
06/03/202315:03Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ELVNEnliven Therapeutics Inc
01/03/202315:57Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ELVNEnliven Therapeutics Inc
23/02/202316:20GlobeNewswire Inc.Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 MillionNASDAQ:ELVNEnliven Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ELVN